Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data for ELI-200, an Opioid Abuse Deterrent Product
September 09, 2014 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today reported top line results from a Human Abuse Liability (HAL) study for the...
InnoPharma Inc. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States
August 15, 2013 08:00 ET
|
InnoPharma, Inc
PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc.
today announced the launch of acamprosate calcium, 333 mg
delayed-release tablets (generic equivalent of
Campral®). ...
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Third Quarter Investor Conference Call on Tuesday, February 19, 2013
February 13, 2013 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 13, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
February 06, 2013 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 31, 2012, the U.S. Food and Drug Administration approved the...
Elite Pharmaceuticals, Inc. Announces First Shipments From Expanded 15,000 Square Foot Facility
January 28, 2013 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite is now using and shipping packaged product from its...
PBMI Survey Finds Retail Copays Are Increasing Across All Drug Types
December 19, 2012 11:12 ET
|
Pharmacy Benefit Management Institute
PLANO, TX--(Marketwire - Dec 19, 2012) - Retail copays are on the rise again across all drug types, including generics, brands and specialty drugs. This is just one of the reported...
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
November 15, 2012 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012
November 13, 2012 13:34 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference on February 14, 2011
February 08, 2011 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing...